Business
BioSpectrum Asia
Kyorin and Lunatus partner to launch Lasvic tablets in 9 Middle Eastern countries
Japan's Kyorin Pharmaceutical has entered into an exclusive distribution agreement with Lunatus Marketing & Consulting FZCO for Lasvic tablets (Lascufloxacin hydrochloride).
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Biotium launches GlycoLiner Cell Surface Glycoprotein Labeling Kits
US-based Biotium, a leading innovator in fluorescent dyes and life science reagents, has announced the launch of GlycoLiner Cell Surface Glycoprotein Labeling Kits for rapid, selective, and covalent labeling of cell surface glycoproteins.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Vaxxas appoints former Merck Global Vaccines President David Peacock as CEO
Australia-based Vaxxas has announced the appointment of global biopharmaceutical executive David Peacock as Chief Executive Officer (CEO) to lead the commercialisation of the company's proprietary high-density microarray patch (HD-MAP) vaccination technology.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Thermo Fisher partners with NVIDIA leveraging AI to advance scientific instrumentation
US-based Thermo Fisher Scientific Inc. has announced a strategic collaboration with NVIDIA to power artificial intelligence (AI)based solutions and laboratory automation at scale.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Bruker consolidates ownership of TOFWERK in expansion of mass spectrometry portfolio
Bruker Corporation has announced the acquisition of an additional 60 per cent ownership stake in TOFWERK AG, a Switzerland-based innovator in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets, consolidating Bruker's ownership to 100 per cent.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Bioengineered tissue by Japan emerges as revolutionary treatment for secondary lymphedema
A research team led by Associate Professor Kosuke Kusamori from the Faculty of Pharmaceutical Sciences at Tokyo University of Science (TUS), Japan, is pioneering an innovative technique for lymphatic tissue engineering that could revolutionize the treatment of secondary lymphedema.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Chitose and Fujifilm Biosciences to drive global innovation and biopharma manufacturing
Japan-based Chitose Laboratory Corp. & Fujifilm Biosciences Inc. have announced a new strategic alliance that leverages the strengths of both companies in advancing biopharmaceutical production.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Vibrant Therapeutics on-boards Dr Han Lee as Co-CEO
Vibrant Therapeutics, a clinical-stage biotechnology company based in China and US, has announced the appointment of Dr Han Lee as co-chief executive officer (CEO).
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
IIT-D and AIIMS develop swallowable microdevice for microbiome study
Researchers at the Indian Institute of Technology (IIT) Delhi, and All India Institute of Medical Sciences (AIIMS) have developed an ingestible device that can sample bacteria directly from the small intestine, opening a new window into the human gut microbiome.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Ambitious research to develop multivalent vaccines against multiple deadly filoviruses
Scientists at the University of Oxford, in collaboration with partners, will spearhead the development of new vaccines that aim to provide comprehensive protection against multiple lethal filoviruses, including Ebola virus, Sudan virus, Bundibugyo virus, and Marburg virus.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Korea opens door to B cell-based personalised cancer vaccines
Researchers from the Department of Bio and Brain Engineering at Korea Advanced Institute of Science and Technology (KAIST), in collaboration with Neogen Logic Co., have developed a new artificial intelligence (AI) model to predict neoantigens, a core element of personalised cancer vaccine development, and clarified the importance of B cells in cancer immunotherapy.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
JNCASR and CrisprBits to set up CRISPR Centre of Excellence in Innovation and Translation
A Letter of Intent (LOI) has been signed for the establishment of CRISPR Centre of Excellence for Innovation & Translation (CoE-CIT).
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Beckman Coulter Life Sciences unveils Biomek i3 Benchtop Liquid Handler
Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, makes liquid handling research more accessible with the launch of the Biomek iz Benchtop Liquid Handler.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Chad May steps in as Chief Scientific Officer at Orum Therapeutics
Orum Therapeutics, a biotechnology company based in the US and South Korea, has announced the appointment of Dr Chad May as Chief Scientific Officer (CSO).
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
PAHO reviews measles elimination status in United States and Mexico
The Pan American Health Organization (PAHO) Regional Monitoring and Re-Verification Commission for Measles, Rubella, and Congenital Rubella Syndrome (RVC) has invited the United States and Mexico to meet virtually on April 13, 2026, to review their measles elimination status.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
US FDA approves first treatment for children with Menkes Disease
The US Food and Drug Administration (FDA) has approved the Zycubo (copper histidinate) injection, to Sentynl Therapeutics, as the first treatment for Menkes disease in paediatric patients.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
SINGAPORE SHOWS WHAT TARIFFS CAN'T
While U.S. President Donald Trump was publicly defending his threat of higher import tariffs on medicines, Singapore was quietly experiencing an unexpected upside: a surge in pharmaceutical production.
2 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Hong Kong designs mucus-inspired hydrogel to boost gastrointestinal wound healing
The Hong Kong Polytechnic University (PolyU) has developed an acid-resistant “ultra-stable mucus-inspired hydrogel” (UMIH), marking a breakthrough in the field of gastrointestinal medicine.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Africa lifts Mpox as Public Health Emergency of Continental Security
Africa has officially lifted Mpox as a Public Health Emergency of Continental Security following recommendations from the Africa CDC Emergency Consultative Group.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Revvity introduces AI-augmented design platform for molecular and materials discovery
US-based Revvity, Inc. has announced the introduction of its forthcoming Signals Xynthetica Models-as-a Service (MaaS) AI offering within the Revvity Signals platform.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Singapore's NUS launches premier Executive Master Programme to shape Asia's digital future
To address the anticipated shortage of leaders capable of turning artificial intelligence (AI) potential into economic reality, the Asian Institute of Digital Finance (AIDF) at the National University of Singapore has officially launched the inaugural Executive Master in Artificial Intelligence and Digital Transformation (EMAI).
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Nuevocor names AI Gianchetti as CEO
Singapore-based biotech company Nuevocor has announced the appointment of AI Gianchetti as Chief Executive Officer (CEO) and member of the Board of Directors.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
US announces major policy shift to end use of human foetal tissue
The National Institutes of Health (NIH) in the US has announced a new policy ending the use of human foetal tissue in NIH-supported research, marking a significant milestone in the Trump Administration's efforts to modernise biomedical science and accelerate innovation.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Spider venom drug enters clinical trial in Australia for heart attack, stroke treatment
A potential treatment for heart attack and stroke, derived from a spider venom molecule identified by Australia-based University of Queensland (UQ) researchers, has been administered to the first participants in a clinical trial.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Singapore finds new way to restore healing in chronic wounds
An international team of scientists, led by Nanyang Technological University, Singapore (NTU Singapore), has discovered a new way that could speed up the healing of chronic wounds infected by antibioticresistant bacteria.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Akums signs MoU with Sharda University to strengthen industryacademia collaboration
India-based Akums Drugs & Pharmaceuticals, a contract development and manufacturing organization (CDMO), has signed a Memorandum of Understanding (MoU) with Sharda University, Agra, to foster long-term collaboration in pharmaceutical research, technology transfer, and skill development.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Teoxane opens first APAC regional academy for medical education in Bangkok
Teoxane has opened its first APAC Regional Academy in Bangkok, expanding its global medical-education network.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Novotech appoints Dr Anand Tharmaratnam as new Chief Executive Officer
Novotech, a globally recognized full-service biotech clinical research organisation (CRO) has announced the appointment of D Anand Tharmaratnam as its new Chief Executive Officer (CEO).
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
US announces major policy shift to end use of human foetal tissue
The National Institutes of Health (NIH) in the US has announced a new policy ending the use of human foetal tissue in NIH-supported research, marking a significant milestone in the Trump Administration's efforts to modernise biomedical science and accelerate innovation.
1 min |
BioSpectrum Asia Feb 2026
BioSpectrum Asia
ErlySign ropes in Vishal Kumar as Vice President Business
ErlySign, a biotech startup developing India's first salivary biomarker-based screening test for early-stage oral cancer, has announced the appointment of Vishal Kumar as Vice President - Business.
1 min |